Korro Bio
Korro Bio is a Cambridge, Mass.-based provider of a platform for RNA editing to modulate protein function for therapeutic applications.
Last updated on
About Korro Bio
Founded
2018Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$208MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesKorro Bio
Find your buyer within Korro Bio